Modeling 1-year Relapse-free Survival After Neoadjuvant Chemotherapy and Radical Cystectomy in Patients with Clinical T2–4N0M0 Urothelial Bladder Carcinoma: Endpoints for Phase 2 Trials

BACKGROUND: Several ongoing phase 2 trials are evaluating new neoadjuvant therapy regimens in patients with muscle-invasive bladder cancer (MIBC). The 1-yr recurrence-free survival (RFS) after radical cystectomy (RC), with or without perioperative chemotherapy, can be used to model statistical assum...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur Urol Oncol
Main Authors: Bandini, Marco, Briganti, Alberto, Plimack, Elizabeth R., Niegisch, Gunter, Yu, Evan Y., Bamias, Aristotelis, Agarwal, Neeraj, Sridhar, Srikala S., Sternberg, Cora N., Vaishampayan, Ulka, Theodore, Christine, Rosenberg, Jonathan E., Bellmunt, Joaquim, Galsky, Matthew D., Montorsi, Francesco, Necchi, Andrea
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7552889/
https://ncbi.nlm.nih.gov/pubmed/31200838
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.euo.2018.08.009
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados